Status:
COMPLETED
Quality of Life of Patients With Desmoid-type Fibromatosis
Lead Sponsor:
Erasmus Medical Center
Collaborating Sponsors:
Radboud University Medical Center
The Netherlands Cancer Institute
Conditions:
Desmoid Tumor
Desmoid-type Fibromatosis
Eligibility:
All Genders
18+ years
Brief Summary
Rationale: Desmoid-type fibromatosis (DTF) is a rare, histologically benign, soft tissue tumour. Although incapable of metastasizing, the clinical course is unpredictable and can be aggressive because...
Detailed Description
Objectives: The primary objective is to evaluate HRQoL problems in adult DTF patients. The secondary objectives are: 1) to compare the level of HRQoL of DTF patients to the general population, 2) to i...
Eligibility Criteria
Inclusion
- Aged 18 years and older
- Histopathological proven DTF, regardless of disease stage or treatment.
- Diagnosed between January 1990 and July 2020, with a visit to the hospital for their DTF (between October 2014 and July 2020)
- Sufficient Dutch language skills
- Competent to complete a questionnaire
- Written informed consent
Exclusion
- • Familial adenomatous polyposis (FAP)
Key Trial Info
Start Date :
August 6 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2021
Estimated Enrollment :
156 Patients enrolled
Trial Details
Trial ID
NCT04289077
Start Date
August 6 2020
End Date
February 1 2021
Last Update
September 7 2023
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
3. Antoni van Leeuwenhoek Ziekenhuis (AVL) / The Netherlands Cancer Instituut , Amsterdam, The Netherlands
Amsterdam, Netherlands, 1066 CX
2
Radboud University Medical Center (MC), Nijmegen, The Netherlands
Nijmegen, Netherlands, 6525 GA
3
Erasmus MC Cancer Institute
Rotterdam, Netherlands, 3015 GD
4
Royal Marsden NHS Foundation Trust
London, United Kingdom, SW3 6JJ